Advanced Cell Diagnostics (ACD)

Advanced Cell Diagnostics (ACD)

生物技术研究

Newark,CA 18,833 位关注者

RNA expression like you've never seen before

关于我们

ACD - a Bio-Techne brand, (www.acdbio.com) shortens the path to personalized medicine and enables research, drug development and clinical applications by unlocking the power of RNA. ACD is a leader in the emerging field of molecular pathology, developing cell- and tissue-based research and diagnostic tests for personalized medicine. Based in Silicon Valley, ACD was founded and managed by experienced entrepreneurs in the life science industry. ACD’s products and pharma assay services are based on its proprietary RNAscope? technology ( 10,000+ publications), the first multiplex fluorescent and chromogenic in situ hybridization platform, capable of detecting and quantifying single molecules of RNA in situ. ACD has two product lines, namely RNAscope and BaseScope? in addition to a Professional Assay Services business. The catalog includes >50,000 target probes and assay kits for single, duplex and multiplex RNA analysis. www.acdbio.com

网站
https://www.acdbio.com
所属行业
生物技术研究
规模
51-200 人
总部
Newark,CA
类型
上市公司
创立
2006
领域
RNA ISH、RNAscope、RNA in situ hybridization、RNA biomarkers、Quantitative Molecular Detection、Morphological Context、Single Cell Analysis、RNA-Seq、Chromogenic in situ hybridization (CISH)、Fluorescent in situ hybridization (FISH)、splice variants、antibody validation 、companion diagnostics 、precision medicine 、pathology、ISH、BaseScope、CDx、cancer、neuroscience、gene therapy、safety toxicology 、target validation 和IHC

地点

Advanced Cell Diagnostics (ACD)员工

动态

相似主页

查看职位

融资